Auspex Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel medicines for the treatment of orphan diseases.
http://www.auspexpharma.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Wednesday
LOAD TIME
PERFECT PRIVACY, LLC
12808 Gr●●●●●●●●kwy West
Jack●●●●ille , FL, 32258
US
View this contact
PERFECT PRIVACY, LLC
12808 Gr●●●●●●●●kwy West
Jack●●●●ille , FL, 32258
US
View this contact
PERFECT PRIVACY, LLC
12808 Gr●●●●●●●●kwy West
Jack●●●●ille , FL, 32258
US
View this contact
BUY YOUR DOMAIN
23
YEARS
2
MONTHS
15
DAYS
REGISTER.COM, INC.
WHOIS : whois.register.com
REFERRED : http://www.register.com
PAGES IN
THIS WEBSITE
7
SSL
EXTERNAL LINKS
19
SITE IP
204.74.99.101
LOAD TIME
0 sec
SCORE
6.2
Auspex Pharmaceuticals | A novel approach to the treatment of orphan hyperkinetic movement disorders | auspexpharma.com Reviews
https://auspexpharma.com
Auspex Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel medicines for the treatment of orphan diseases.
Investor Relations - Auspex Pharmaceuticals
For Patients and Family. Auspex's lead compound, SD-809, is being developed for the treatment of the involuntary movements that characterize several neurological disorders including Huntington's Disease, Tourette Syndrome and Tardive Dyskinesia. Auspex (Nasdaq: ASPX) was founded in 2001 and is headquartered in San Diego, California. 4:00 PM ET on May 4, 2015. Delayed at least 20 minutes. May 5, 2015. Teva Completes Acquisition of Auspex Pharmaceuticals. Mar 30, 2015. View all press releases ».
auspexpharma.com
News/Events Auspex | Auspex Pharmaceuticals
http://www.auspexpharma.com/news-events
For Patients & Family. Events & Presentations. Financials & Filings. Press Releases / Events. Auspex's lead compound, SD-809, is being developed for the treatment of the involuntary movements that characterize several neurological disorders including Huntington's disease, Tourette syndrome and tardive dyskinesia. Press Releases / Events. January 01, 1970. 124; read more. January 01, 1970. 124; read more.
Pipeline | Auspex Pharmaceuticals
http://www.auspexpharma.com/pipeline
For Patients & Family. Events & Presentations. Financials & Filings. Press Releases / Events. Auspex's lead compound, SD-809, is being developed for the treatment of the involuntary movements that characterize several neurological disorders including Huntington's Disease, Tourette Syndrome and Tardive Dyskinesia. Deuterium-containing pirfenidone analog (SD-560).
Clinical Trials | Huntington's Disease | Auspex Pharmaceuticals
http://www.auspexpharma.com/clinical-trials
For Patients & Family. Events & Presentations. Financials & Filings. Press Releases / Events. Auspex's lead compound, SD-809, is being developed for the treatment of the involuntary movements that characterize several neurological disorders including Huntington's Disease, Tourette Syndrome and Tardive Dyskinesia. Ongoing Clinical Development of SD-809. Phase 3 placebo-controlled registration trial. Open-label switch and long-term safety clinical trial. Phase 1b clinical trial in Tourette syndrome.
Investors | Auspex Pharmaceuticals
http://www.auspexpharma.com/about-auspex/investors
For Patients & Family. Events & Presentations. Financials & Filings. Press Releases / Events. Auspex's lead compound, SD-809, is being developed for the treatment of the involuntary movements that characterize several neurological disorders including Huntington's Disease, Tourette Syndrome and Tardive Dyskinesia. Auspex Pharmaceuticals’ investors include Thomas, McNerney and Partners, CMEA Capital, Panorama Capital, Sloan Biotech Funds and BioMed Ventures.
For Patients and Families | Huntington's Disease | Auspex Pharmaceuticals
http://www.auspexpharma.com/for-patients-and-family
For Patients & Family. Events & Presentations. Financials & Filings. Press Releases / Events. Auspex's lead compound, SD-809, is being developed for the treatment of the involuntary movements that characterize several neurological disorders including Huntington's disease, Tourette syndrome and tardive dyskinesia. For Patients and Family. Presentation of SD-809 for the Treatment of Chorea Associated with Huntington's Disease. June 22, 2013. Huntington's Disease Society of America.
TOTAL PAGES IN THIS WEBSITE
7
Teva rachète Auspex Pharmaceuticals pour 3,2 Md$ - Actulabo
http://www.actulabo.com/article/teva--rachete-auspex-pharmaceuticals-pour-3-2-md-,1757.php
Teva rachète Auspex Pharmaceuticals pour 3,2 Md$. Le 30 Mars 2015. La direction de Teva. Qui avait annoncé ces dernières semaines qu’elle entendait renforcer ses positions dans le domaine des pathologies orphelines, vient de joindre le geste à la parole. La big pharma d’origine israélienne annonce ce jour l’acquisition pour environ 3,2 Md$ d’ Auspex Pharmaceuticals.
Alexion rachète Synageva BioPharma pour 8,4 Md$ - Actulabo
http://www.actulabo.com/article/alexion-rachete-synageva-biopharma-pour-8-4-md-,1763.php
Alexion rachète Synageva BioPharma pour 8,4 Md$. Le 06 Mai 2015. Le secteur des maladies rares stimule toujours le marché des M&A. La biopharm américaine Alexion Pharmaceuticals. Vient d’annoncer l’acquisition au prix de 230 $ par action, soit 8,4 Md$, de sa compatriote Synageva BioPharma. Rappelons, toujours sur le segment des maladies rares, que Teva. S’est emparé le 30 mars dernier d’ Auspex Pharmaceuticals. Pour 3,2 Md$. La veille, lirlandais Shire.
rb Venture Capital: Portfolio Companies
http://www.rbventurecapital.com/portfolio.htm
Helping companies accelerate through growth". RBVC has equity stakes and/or consulting relationships with the following companies:. Is a mobile application that allows users to add their favorite web services to their phone s sleep screen, enabling zero-click access to the content they use most. FlyScreen eliminates unnecessary clicking and navigating, is extremely customizable, and can support a broad range of web services. Is a service company with proprietary software for selling pre-owned cars. M...
Thomas McNerney & Partners
http://www.tm-partners.com/news/033015.html
TEVA REINFORCES LEADERSHIP POSITION IN CNS WITH ACQUISITION OF AUSPEX. Expected to strengthen Teva's core CNS franchise, establish Teva's leadership in underserved movement disorders space, provide compelling new treatment options for patients in need, and enhance Teva's long-term revenue and earnings growth. All-Cash Transaction with Enterprise Value of $3.2 Billion. Auspex is an innovative biopharmaceutical company specializing in applying deuterium chemistry to known molecules to create novel therapie...
Foresite Capital
http://www.foresitecapitalmanagement.com/portfolio
Since inception in 2011, we have invested in and helped build transformative category-defining companies across the therapeutics, devices,. Diagnostics, and services sectors. AcelRx Pharmaceuticals, Inc. Aduro BioTech (Nasdaq: ADRO) is a clinical stage cancer immuno-oncology company focused on the development of first-in-class technology platforms and products designed to stimulate robust and durable immune responses against cancer. Its lead product candidate, CRS-207, is currently being developed fo...
APRIL 9th Screening CHICAGO - A Mind in Quicksand
http://amindinquicksand.com/april-9th-screening-chicago.html
A Mind in Quicksand. Rent it now $4.99. Check your local listing. APRIL 9th Screening CHICAGO. Globe and Mail - Review by Kerry Gold. A MIND IN QUICKSAND will be. Released on May 1st. To public televisions stations nationally and we are proud to have American Public Television as our broadcast distributor. MAY IS HUNTINGTON'S DISEASE AWARENESS MONTH. THANKS TO EVERYONE FOR JOINING US! THURSDAY, APRIL 9th. FILM ROW CINEMA at Columbia College Chicago. 1104 South Wabash, 8th Floor, ADA Accessible.
TOTAL LINKS TO THIS WEBSITE
19
Auspexi (Michael) - DeviantArt
Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Deviant for 7 Years. This deviant's full pageview. Last Visit: 282 weeks ago. This is the place where you can personalize your profile! By moving, adding and personalizing widgets. Why," you ask?
Home
Or sign in with Facebook. Follow @TheJenATX on Twitter. First of all.WELCOME TO NATIONBUILDER! We are thrilled that you are now part of the most comprehensive, well designed and proactive site platform in existence! Now that you are here, you want to get started as quickly as possible. That's where we come in. We have 4 levels of service available built around flexibility for you and your business:. 1) Per hour consultation. 3) Complete flat fee site buildout (subject to a statement of work).
Bewusstseinsentwicklung
Beratungsangebot für Firmen und Organisationen. Von noumenal bis klassisch. Verbesserung der Lebensqualität für Einzelpersonen. Schamanische Praxis / Seelenpflege. Seminare und Workshops auf noumenaler und pluralistischer Basis. Impulsvorträge zu noumenalen und pluralistischen Themen. Eine pluralistische Sicht auf die Welt und unsere Wirklichkeiten. Das Denken der Seele and Der Zauber des Geistes. CD Die Glücksessenz (Hrsg. Bernd Bechtloff). Auspexis und noumenale Themen in der Presse. Ist pluralistisch:...
www.auspexlabs.com
Auspex Pharmaceuticals | A novel approach to the treatment of orphan hyperkinetic movement disorders
For Patients & Family. Events & Presentations. Financials & Filings. Press Releases / Events. Huntington's Disease ». Tourette Syndrome ». Tardive Dyskinesia ». May 05, 2015. Teva Completes Acquisition of Auspex Pharmaceuticals | read more ». March 30, 2015. Teva Reinforces Leadership Position in CNS with Acquisition of Auspex | read more ».
www.auspexpharmaceuticals.com
Account Suspended
This website is under maintenance and is unavailable. Check back soon!
auspexpropertyinvestment.com.au
Auspex Property Investment
Call Us Today 1300 PROPERTY. For Home Owners ONLY: What’s Wrong With Owning Your Home Alot Sooner, Paying Less Tax And Getting Financially Secure QUICKER? You Don’t Have To Wait Until You Retire, That’s Too Late To Truly Enjoy It…. I was the total skeptic. Not only had I bought and sold many properties over the years, but I had some major successes under my belt. So I just Didn’t want to believe it when a mentor once said to me Do you Have A Rich Uncle? Wise and Experienced Property Partners. Our exclusi...
Crazy Domains | auspexpropertyresearch.asia
PLN zł. RUB руб. Your cart is empty. Your new login information. Enter username or domain name and we will send you login information to the email address on file. If you need further help please contact us. Search and register domain names. World's lowest domain prices. 700 New generic domains. Move your domains to us FREE. Quickly renew your domain names. Get the domain name you want! Everything you need for your domains. Control your CNAME, MX and A records. Find who owns a particular domain. Affordab...
auspexpropertyresearch.com - Crazy Domains
For Domains and Hosting. Search and register domain names. Move your domains to us FREE. Everything you need for your domains. Express cheap domain renewal. Control your CNAME, MX and A records. 700 New global domains. Get the domain name you want. Find who owns a particular domain. Register your domain and Get Started Online. Join The Domain Club. Fast, reliable space for your website. Web Hosting - Transfer. Move your website and email to us. Cloud premium DNS network. Get your own me@mydomain.com.
